Boston An independent LDT provider
NOTE:Immunovia has ceased commercialization of the IMMray PanCan-d test. More information available here:

Webinar No. 3: Verification Study Output

December 17, 2020

Webinar No. 3: IMMray™ PanCan-d Verification study and Clinical Use

Presentations by: Thomas King, MD, PhD, Linda Mellby, PhD, Laura Chirica, PhD, Immunovia

Moderator: Patrik Dahlen, CEO Immunovia

Immunovia interview with Prof. Stephen Pereira, Gastroenterologist and Hepatologist, BSc, PhD, FRCP, FRCPE, at the London Clinic (UCL), Principle Investigator for Immunovia´s PanSYM study in London, UK, in regard to the clinical utility of diagnostic tests in pancreatic cancer, December 8, 2020.

0:00 Introduction and Agenda
1:40 Positioning of IMMray™ PanCan-d in clinical practice
17:45 Verification study vs clinical practice
26:55 Voice of pancreatic cancer experts about IMMray™ PanCan-d clinical utility
41:22 Q&A Session